Document:

Exhibit 10.7

 

NOTE PURCHASE AGREEMENT

 

This NOTE PURCHASE AGREEMENT
(this “Agreement”) is dated as of June 16, 2021, and is made by and among BCP QualTek HoldCo, LLC, a Delaware limited
liability company (the “Company”), and the purchaser of the Note(s) (as defined herein) listed on Exhibit A
hereto (the “Purchaser”), and Roth CH Acquisition III Co., a Delaware corporation (the “SPAC”).

 

RECITALS

 

WHEREAS, the Company
has offered to sell the Purchaser $[l] in aggregate principal amount of one or more convertible
notes of the Company (collectively, the “Notes”);

 

WHEREAS, the Purchaser
is an “accredited investor” as such term is defined in Rule 501 of Regulation D (“Regulation D”) promulgated
under the Securities Act of 1933, as amended (the “Securities Act”);

 

WHEREAS, the offer
and sale of the Notes by the Company is being made in reliance upon the exemption from registration available under Section 4(a)(2) of
the Securities Act; and

 

WHEREAS, the Purchaser
is willing to purchase from the Company Note(s) in the principal amount(s) set forth opposite the Purchaser’s name in Exhibit
A hereto (the “Note Amount”) and in accordance with the terms, subject to the conditions and in reliance on, the
recitals, representations, warranties, covenants and agreements set forth herein and in the Note(s);

 

NOW, THEREFORE, in
consideration of the mutual covenants, conditions and agreements herein contained and other good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows:

 

AGREEMENT

 

		1	PURCHASE AND SALE.

 

		1.1	Purchase. The Purchaser agrees to purchase Note(s) from the Company, in the applicable Note
Amount, on the Closing Date (as defined below) in accordance with the terms of, and subject to the conditions and provisions set forth
in, this Agreement.

 

		1.2	Terms. Attached hereto as Exhibit B is the form Note.

 

		1.3	Closing. Delivery of the Notes will take place against payment therefor through the remote
exchange of documents and signature pages on the date hereof concurrently with the execution and delivery of the BCA (as defined below)
(such date and time, the “Closing Date”). On the Closing Date, the Purchaser will, subject to receipt from the Company
of an executed Form W-9, disburse by wire of immediately available funds the applicable Note Amount to an account designated by the Company.

 

     

     

    

 

		2	CONDITIONS PRECEDENT.

 

		2.1	Conditions to the Purchaser’s Obligation. The obligations of the Purchaser to consummate
the purchase of the Notes on the Closing Date is subject to satisfaction of the following (or waiver by the Purchaser):

 

		(a)	Agreement. The Company will have duly executed and delivered this Agreement.

 

		(b)	Registration Rights. The SPAC shall have delivered a duly executed counterpart to the Registration
Rights Agreement in the form of Exhibit C attached hereto (the “Registration Rights Agreement”).

 

		(c)	Business Combination Agreement. Each party to the BCA (as defined below) shall have duly
executed and delivered the Business Combination Agreement (the “BCA”), dated as of the date hereof, by and among (i)
the SPAC, (ii) Roth CH III Blocker Merger Sub, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company, (iii)
BCP QualTek Investors, LLC, a Delaware limited liability company, (iv) Roth CH III Merger Sub, LLC, a Delaware limited liability company
and wholly-owned subsidiary of the Company, (v) the Company and (vi) BCP QualTek, LLC, solely in its capacity as representative of the
Blocker Owners (as defined therein) and the Company Unitholders (as defined therein).

 

		(d)	No Amendments to the Other Notes. Other convertible notes issued pursuant to a Note Purchase
Agreement with the Company on or around the date hereof (other than convertible notes issued to BCP QualTek II, LLC or an affiliate thereof)
shall include no provision that materially advantages or is materially more favorable to any other noteholder (for example, without limitation,
a higher discount or lower conversion price) as compared to the Purchaser, and in the event the Company amends any such instruments while
the Note held by the Purchaser is outstanding so as to materially advantage or favor any other noteholder, then the Company shall execute
amendments to the Note necessary to grant the same materially advantageous or more favorable terms to the Note held by the Purchaser;
provided that the Company may provide board observer rights to any noteholder that purchases Notes in an aggregate principal amount
that is not less than $20,000,000.

 

		(e)	Representations and Warranties. All representations and warranties of the Company contained
in this Agreement shall be true and correct in all material respects as of the Closing Date (other than those representations and warranties
expressly made as of an earlier date, which shall be so true and correct in all respects as of such date).

 

		2.2	Conditions to the Company’s Obligation. The
obligation of the Company to consummate the sale of the Notes is additionally subject to each of the following (or written waiver by the
Company):

 

		(a)	Agreement. The Purchaser will have duly executed and delivered this Agreement.

 

    	 	2	 

     

    

 

		(b)	Registration Rights. The Purchaser shall have delivered a duly executed counterpart to the
Registration Rights Agreement.

 

		(c)	Business Combination Agreement. Each party to the BCA (other than the Company) shall
have duly executed and delivered the BCA.

 

		(d)	Disbursement. The Company shall have received the applicable Note Amount in immediately
available funds in accordance with Section 1.

 

		(e)	Tax Form. The Purchaser will have provided the Company a properly completed and duly executed
IRS Form W-9.

 

		(f)	Representations and Warranties. All representations and warranties of the Purchaser contained
in this Agreement shall be true and correct in all material respects as of the Closing Date (other than those representations and warranties
expressly made as of an earlier date, which shall be so true and correct in all respects as of such date).

 

		3	REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY.

 

The Company hereby represents
and warrants to the Purchaser as follows:

 

		3.1	Organization, Qualification and Authority. The Company is a duly organized limited liability
company, is validly existing under the laws of the State of Delaware and has all requisite limited liability company power and authority
to conduct its business and activities as presently conducted, to own its properties, and to perform its obligations under this Agreement.
The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure to so qualify or
to be in good standing would have a material adverse effect on the Company.

 

		3.2	Agreement. This Agreement has been duly authorized, executed and delivered by the Company,
and, assuming due execution and delivery by the other parties thereto, constitutes the legal, valid and binding obligation of the Company,
enforceable against the Company in accordance with its terms, except as enforcement thereof may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws relating to or affecting creditors’ rights generally or by general equitable principles.

 

		3.3	Issuance of Notes. The Notes are duly authorized and, when issued
and paid for in accordance with this Agreement, will be valid and binding obligations of the Company, enforceable against the Company
in accordance with their terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.

 

		3.4	No Conflicts. The execution and delivery by the Company of this Agreement and the performance
by the Company of its covenants and obligations hereunder will not violate or conflict with (i) any provision
of the organizational documents of the Company, (ii) any material agreement to which the Company is a party, (iii) any legal
requirements applicable to the Company or its properties or assets or (iv) any order, writ, judgment, injunction or decree applicable
to the Company, except, in the case of clauses (ii), (iii) and (iv), for any such violation or conflict that would not reasonably be expected
to have a material adverse effect on the business, assets, properties, financial position or results of operations of the Company and
its subsidiaries, taken as a whole.

 

    	 	3	 

     

    

 

		3.5	No Registration. Assuming the accuracy of the Purchaser’s
representations and warranties set forth herein, in connection with the offer, sale and delivery of the Notes in the manner contemplated
hereby, it is not necessary to register the offer and sale of the Notes under the U.S. Securities Act of 1933, as amended (the “Securities
Act”). The Notes (i) were not offered to Purchaser by any form of general solicitation or general advertising and (ii) are not being
offered in a manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities
laws.

 

		3.6	Capitalization. 

 

		(a)	Schedule 4.3(a)(i) of the Disclosure Schedules to the BCA sets forth the issued and outstanding
Company Equity Interests (including the number and class or series (as applicable) of Equity Interests (each as defined in the BCA)) and
the record and beneficial ownership thereof as of the date hereof. The Equity Interests set forth on Schedule 4.3(a)(i) of
the Disclosure Schedules to the BCA comprise all of the limited liability company interests or other Equity Interests of the Company that
are issued and outstanding, in each case, as of the date hereof and immediately prior to giving effect to the transactions occurring on
the date of the closing of the SPAC Combination (including the Pre-Closing Reorganization (each as defined in the BCA)). Schedule 4.3(a)(ii)
of the Disclosure Schedules to the BCA sets forth the issued and outstanding Company Equity Interests (including the number and class
or series (as applicable) of Equity Interests) and the record and beneficial ownership (including the percentage interests held thereby)
thereof as of the date hereof and assuming the consummation of, and after giving effect to, the Pre-Closing Reorganization.

 

		(b)	Except as set forth on Schedule 4.3(b) of the Disclosure Schedules to the BCA or the Second
Amended and Restated Limited Liability Company Agreement of the Company, dated as of October 4, 2019 (the “Company LLCA”):

 

(i)               there are no outstanding options, warrants, contracts, calls, puts, rights to subscribe, conversion rights or other similar
rights to which the Company is a party or which are binding upon the Company providing for the offer, issuance, redemption, exchange,
conversion, voting, transfer, disposition or acquisition of any of its Equity Interests;

(ii)             
the Company is not subject to any obligation (contingent or otherwise) to repurchase or otherwise acquire or retire any
of its Equity Interests or the Equity Interests of another person;

 

    	 	4	 

     

    

 

(iii)           
 the Company is not a party to any voting trust, proxy or other agreement or understanding with respect to the voting of
any of its Equity Interests;

 

(iv)            
there are no contractual equityholder preemptive or similar rights, rights of first refusal, rights of first offer or registration
rights in respect of the Company Equity Interests; and

 

(v)             
the Company has not violated in any material respect any applicable securities laws or any preemptive or similar rights
created by law, the certificate of formation (or analogous document) and limited liability company operating agreement of the Company,
or contract to which the Company is a party in connection with the offer, sale, issuance or allotment of any of the Company Equity Interests.

		(c)	All of the Company Equity Interests have been duly authorized and validly issued.

 

		(d)	Schedule 4.3(d) of the Disclosure Schedules to the BCA sets forth a true and complete list of the
Company’s direct and indirect subsidiaries (the “Company Subsidiaries”), listing for each Company Subsidiary
its name, the jurisdiction of its formation or organization (as applicable) and its parent company. Except as set forth on Schedule
4.3(d) of the Disclosure Schedules to the BCA, all of the outstanding Equity Interests of each Company Subsidiary are duly authorized,
validly issued, free of preemptive rights and restrictions on transfer (other than restrictions under applicable federal, state and other
securities laws), and are owned by the Company, whether directly or indirectly, free and clear of all liens (other than Permitted Liens
(as defined in the BCA)). There are no options, warrants, convertible securities, stock appreciation, phantom stock, stock-based performance
unit, profit participation, restricted stock, restricted stock unit, other equity-based compensation award or similar rights with respect
to any Company Subsidiary and no rights, exchangeable securities, securities, “phantom” rights, appreciation rights, performance
units, commitments or other agreements obligating the Company or any Company Subsidiary to issue or sell, or cause to be issued or sold,
any Equity Interests of, or any other interest in, any Company Subsidiary, including any security convertible or exercisable into equity
securities of any Company Subsidiary. There are no contracts to which any Company Subsidiary is a party which require such Company Subsidiary
to repurchase, redeem or otherwise acquire any Equity Interests or securities convertible into or exchangeable for such equity securities
or to make any investment in any other Person.

 

		3.7	Financial
Statements; No Undisclosed Liabilities.

 

		(a)	Attached as Schedule 4.4(a) of the Disclosure Schedules to the BCA are true and complete copies of the following
financial statements (such financial statements, the “Financial Statements:

 

(i)                
the audited consolidated balance sheet of the Company and its subsidiaries as of December 31, 2020 and December 31, 2019
and the related audited consolidated statements of comprehensive loss, cash flows and members’ equity for the fiscal years ended on such dates, together
with all related notes and schedules thereto, accompanied by the reports thereon of the Company’s independent auditors (the “Audited
Financial Statements”); and

 

    	 	5	 

     

    

 

(ii)             
the unaudited consolidated balance sheet of the Company and its subsidiaries (the “Unaudited Balance Sheet”)
as of April 3, 2021 (the “Latest Balance Sheet Date”) and the related unaudited consolidated statements of comprehensive
loss and cash flows for the fiscal quarter then ended (collectively, together with the Unaudited Balance Sheet, the “Unaudited
Financial Statements”).

 

		(b)	Except
as set forth on Schedule 4.4(b) of the Disclosure Schedules to the BCA, the Financial Statements (i) have been prepared from the
books and records of the Company and its subsidiaries; (ii) have been prepared in accordance with United States generally accepted accounting
principles (“GAAP”) applied on a consistent basis throughout the periods indicated, except as may be indicated in
the notes thereto and subject, in the case of the Unaudited Financial Statements, to the absence of footnotes and year-end adjustments;
and (iii) fairly present, in all material respects, the consolidated financial position of the Company and its subsidiaries as of the
dates thereof and their consolidated results of operations and cash flows for the periods then ended (subject, in the case of the Unaudited
Financial Statements, to the absence of footnotes and year-end adjustments, none of which would be expected to be material, individually
or in the aggregate).

 

		(c)	Except
as set forth on Schedule 4.4(e) of the Disclosure Schedules to the BCA, no Group Company has any liabilities that are required
to be disclosed on a balance sheet in accordance with GAAP, except (i) liabilities adequately reserved against in the Financial
Statements; (ii) liabilities which have arisen after the Latest Balance Sheet Date in the Ordinary Course of Business (as defined in
BCA), none of which results from, arises out of or was caused by any infringement or violation of law; (iii) liabilities arising under
this Agreement, the Ancillary Agreements or the performance by the Company of its obligations hereunder or thereunder; or (iv) for fees,
costs and expenses for advisors and affiliates of the Group Companies, including with respect to legal, accounting or other advisors
incurred by the Group Companies in connection with the transaction contemplated by this Agreement and the Ancillary Agreements (as defined
in the BCA).

 

		(d)	Investment Company. The Company is not, and immediately after receipt of the Note Amount, will not be, an “investment company”
within the meaning of the Investment Company Act of 1940, as amended.

 

		4	REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE PURCHASER.

 

The Purchaser hereby represents
and warrants to the Company as follows:

 

		4.1	Organization and Authority. The Purchaser is duly organized,
validly existing and in good standing (or the equivalent thereof, if applicable) under the laws of its respective jurisdiction of formation
or organization (as applicable) and has all requisite corporate, limited liability company or limited partnership (as applicable) power
and authority to conduct its business and activities
as presently conducted, to own its properties, and to perform its obligations under this Agreement.

 

    	 	6	 

     

    

 

		4.2	Execution. This Agreement has been duly executed and delivered by the Purchaser and, assuming
due authorization (if applicable), execution and delivery by the other parties thereto, constitutes the legal, valid and binding obligation
of the Purchaser, enforceable against the Purchaser in accordance with its terms, except as enforcement thereof may be limited by bankruptcy,
insolvency, reorganization, moratorium or other similar laws relating to or affecting creditors’ rights generally or by general
equitable principles.

 

		4.3	No Conflicts. The execution and delivery by the Purchaser of this Agreement and the performance
by such Purchaser of its covenants and obligations hereunder will not violate or conflict with (i)  any provision of the organizational
documents of the Purchaser, (ii) any agreement to which such Purchaser is party, (ii) any legal requirements applicable to such Purchaser
or its properties or assets or (iii) any order, writ, judgment, injunction or decree applicable to such Purchaser, except for any such
conflict that would not materially impair such Purchaser’s ability to perform its obligations under this Agreement.

 

		4.4	Purchase for Investment. The Purchaser is purchasing a Note for its own account and not
with a view to distribution and with no present intention of reselling, distributing or otherwise disposing of the same. The Purchaser
has no present or contemplated agreement, undertaking, arrangement, obligation, indebtedness or commitment providing for, or which is
likely to compel, a disposition of a Note in any manner.

 

		4.5	Accredited Investor. The Purchaser is, and will be on the Closing Date, an “accredited
investor” as such term is defined in Rule 501(a) of Regulation D.

 

		4.6	Financial and Business Sophistication. The Purchaser has such knowledge and experience in
financial and business matters that it, he or she is capable of evaluating the merits and risks of the prospective investment in the Notes.
The Purchaser has relied solely upon its own knowledge of, and/or the advice of its own legal, financial or other advisors with regard
to, the legal, financial, tax and other considerations involved in deciding to invest in the Notes.

 

		4.7	Ability to Bear Economic Risk of Investment. The Purchaser recognizes that an investment
in the Notes involves substantial risk and the Notes will be subject to restrictions on transfer. The Purchaser has the ability to bear
the economic risk of the prospective investment in the Notes, including the ability to hold a Note indefinitely, and further including
the ability to bear a complete loss of all of such Purchaser’s investment.

 

		4.8	Information. The Purchaser acknowledges that: (i) such Purchaser is not being provided with
the disclosures that would be required if the offer and sale of the Notes were registered under the Securities Act, nor is such Purchaser
being provided with any offering memorandum or prospectus prepared in connection with the offer and sale of the Notes; (ii) such Purchaser
has conducted its own examination of the Company, the SPAC and their respective subsidiaries and the terms of the Notes to the extent
the Purchaser deems necessary to make its decision to invest in the Notes; and (iii) such Purchaser has availed itself of available financial and other
information concerning the Company, the SPAC and their respective subsidiaries to the extent the Purchaser deems necessary to make its
decision to purchase a Note. The foregoing, however, does not limit or modify the representations, warranties and covenants of the Company
in Section 2 of this Agreement or the right of the Purchasers to rely thereon.

 

    	 	7	 

     

    

 

		4.9	Access to Information. The Purchaser acknowledges that it, he or she and its advisors have
been furnished with all materials relating to the business, finances and operations of the Company, the SPAC and their respective subsidiaries
that have been requested by such Purchaser or its advisors and have been given the opportunity to ask questions of, and to receive answers
from, persons acting on behalf of the Company concerning terms and conditions of the transactions contemplated by this Agreement in order
to make an informed and voluntary decision to enter into this Agreement and to invest in the Notes. The foregoing, however, does not limit
or modify the representations, warranties and covenants of the Company in Section 2 of this Agreement or the right of the Purchasers
to rely thereon.

 

		4.10	Investment Decision. The Purchaser has made its own investment decision based on its own
judgment, due diligence and advice from such advisors as it, he or she has deemed necessary and not based on any view expressed by any
other person or entity. The Purchaser is not relying upon, and has not relied upon, any advice, statement, representation or warranty
made by any person by or on behalf of the Company, its agents, attorneys, other advisors or its or their respective affiliates, except
for the express statements, representations and warranties of the Company made or contained in this Agreement and any other representations
and warranties are disclaimed by the Company, its affiliates and their respective agents and advisors. Furthermore, the Purchaser acknowledges
that nothing in this Agreement or any other materials presented by or on behalf of the Company to such Purchaser in connection with the
purchase of the Notes constitutes legal, tax or investment advice.

 

		4.11	Private Placement; No Registration; Restricted Legends. The Purchaser understands and acknowledges
that the Notes are being sold by the Company without registration under the Securities Act in reliance on the exemption from registration
set forth in Section 4(a)(2) of the Securities Act, and accordingly the Notes may be resold, pledged or otherwise transferred only if
exemptions from the Securities Act and applicable state securities laws are available to the Purchaser. The Purchaser is not subscribing
for Notes as a result of or subsequent to any advertisement, article, notice or other communication published in any newspaper, magazine
or similar media or broadcast over television or radio, or presented at any seminar or meeting. The Purchaser further acknowledges and
agrees that all certificates or other instruments representing the Notes will bear the restrictive legend. The Purchaser further acknowledges
its primary responsibilities under the Securities Act and, accordingly, will not sell or otherwise transfer the Notes or any interest
therein without complying with the requirements of the Securities Act and the rules and regulations promulgated thereunder and the requirements
set forth in this Agreement.

 

    	 	8	 

     

    

		

                                                   4.12
	No Market. The Purchaser will purchase a Note directly from the Company and not from any
placement agent or underwriter and the Purchaser understands that none of the Company or any broker or dealer has any obligation to make
a market in the Notes.

 

		4.13	Accuracy of Representations. The Purchaser understands that the Company will rely on the
truth and accuracy of the foregoing representations, acknowledgements and agreements in connection with the transactions contemplated
by this Agreement and agrees that if any of the representations or acknowledgements made by it are no longer accurate as of the Closing
Date, or if any of the agreements made by it are breached on or prior to the Closing Date, such Purchaser will promptly notify the Company.

 

		5	COMPANY AGREEMENT WITH SPAC AND SPAC ACKNOWLEDGEMENT

 

		5.1	Acknowledgement. The SPAC hereby acknowledges and agrees that,
as of the date of the consummation of the transactions contemplated by the BCA, to the extent it is the IPO Issuer, as defined in the
Note, it will issue fully-paid and non-assessable shares of Class A common stock upon contribution to its capital of the Notes by the
Purchaser at a price of $8.00 per share in accordance with the terms of paragraph 3(a) of the Notes. 

 

		5.2	Termination. If the BCA is not executed or is terminated prior
to consummation of the transactions contemplated thereby, the SPAC’s obligations under this Section 5 shall terminate. 

 

		6	OTHER COVENANTS

 

The Purchaser, the Company and the
SPAC will use commercially reasonable efforts to amend this Agreement, the Note, the A&R LLCA Agreement, the BCA (including the
Ancillary Agreements thereunder) and any other documents as such parties deem reasonably necessary (collectively, the
 “Amendments”), on such terms as are customary and reasonably acceptable to the parties, such that upon the
consummation of the SPAC Combination (as defined in the Note), the Note automatically converts into Common Units (along with a
corresponding number of shares of Buyer Class B Voting Stock), in lieu of converting into common equity of the IPO Issuer (as
defined in the Note) as currently contemplated in Section 3(a) of the Note. The number of Common Units and Buyer Class B Voting
Stock will be equal to the quotient that results from dividing the aggregate principal amount of the Note by $8.00 (as may be
adjusted pursuant to Section 3(a) of the Note). The Common Units, which for the avoidance of doubt shall not be Earnout Common
Units, shall (i) have the same rights as to distributions and liquidation as other Common Units issued at the Closing pursuant to
the Company A&R LLCA (the “Other Common Units”), (ii) be exchangeable in accordance with the Company A&R
LLCA and otherwise on terms and conditions consistent with those generally applicable to the Other Common Units and not subject to
any lock-ups (including any lock-ups currently set forth in the Investor Rights Agreement), (iii) entitle the Purchaser to vote or
consent on any matters permitted to be voted on by holders of Common Units pursuant to the terms of the Company A&R LLCA and, to
the extent not inconsistent therewith, the Delaware Limited Liability Company Act, 6 Del. C. § 18-101, et seq., (iv) except as
set forth in the Company A&R LLCA, not be subject to redemption, repurchase or any “call” rights without the prior
consent of the Purchaser, (v) not subject the Purchaser to the doctrine of corporate opportunities, or any analogous doctrine, in
accordance with Section 8.3 of the Company A&R LLCA and (vi) include such other terms as mutually agreed to between the parties.
Notwithstanding anything to the contrary contained in this Agreement or the Note, the Purchaser shall not be a party to, and shall
not be entitled to any benefits under the Tax Receivables Agreement. The shares of Class A Common Stock of the SPAC issuable upon
exchange of the Purchaser’s Common Units and Buyer Class B Voting Stock shall be included in the definition of
 “Registrable Securities” as defined in, and entitling the Purchaser under, the Registration Rights Agreement, subject to
the exceptions set forth in such definition.

 

    	 	9	 

     

    

 

As promptly as practicable, but in any
event prior to the Closing Date, the Company, the Purchaser and the SPAC shall prepare the necessary drafts, obtain the necessary corporate
approvals and execute all necessary documents to effectuate the Amendments contemplated by this Section 6, including, in the case of the
Purchaser, as a condition to the issuance of the Common Units and the Buyer Class B Voting Stock, become party and execute a joinder to
the Company A&R LLCA at the Closing whereupon the Purchaser shall be bound by, and entitled to the benefits and subject to the obligations
of, the provisions of such agreement; provided, however, that in no event shall the Purchaser or its Affiliates shall be subject to any
non-compete, non-solicitation or other restrictive covenants or have any obligation to contribute capital to the Company or provide any
indemnities for the benefit of the Company.

 

For purposes of this Section 6, all
defined terms used but not defined herein shall be ascribed the meaning given to such terms in the BCA, including the reference to the
Company A&R LLCA, which shall mean the form attached to the BCA as may be amended in accordance with the terms of this Section 6.

 

		7	MISCELLANEOUS.

 

		7.1	Waiver or Amendment. No waiver of any provision or condition hereof shall be valid unless
the same shall be in writing and signed by the party against which such waiver is to be enforced. No waiver by any party of any default,
breach of representation or warranty or breach of covenant hereunder, whether intentional or not, shall be deemed to extend to any other,
prior or subsequent default or breach or affect in any way any rights arising by virtue of any other, prior or subsequent such occurrence.

 

		7.2	Interpretation7.3.
The use of a particular pronoun herein will not be restrictive as to gender or number but will be interpreted in all cases as the context
may require.

 

		7.4	Severability. Whenever possible, each provision hereof shall be interpreted in such manner
as to be effective and valid under applicable law, but if any provision hereof or the application of any such provision to any person
or circumstance shall be held to be prohibited by or invalid, illegal or unenforceable under applicable law in any respect by a court
of competent jurisdiction, such provision shall be ineffective only to the extent of such prohibition or invalidity, illegality or unenforceability,
without invalidating the remainder of such provision or the remaining provisions hereof. Furthermore, in lieu of such illegal, invalid or unenforceable
provision, there shall be added automatically as a part hereof a legal, valid and enforceable provision as similar in terms to such illegal,
invalid, or unenforceable provision as may be possible.

 

    	 	10	 

     

    

 

		7.5	Successors and Assigns. This Agreement will inure to the benefit of the parties and their
respective heirs, legal representatives, successors and assigns. The term “successors and assigns” will not include a purchaser
of a Note from a Purchaser merely because of such purchase.

 

		7.6	Entire Agreement. This
Agreement (together with the exhibits to this Agreement including the Notes(s)) contain the entire agreement and understanding among the
parties with respect to the subject matter hereof and thereof and supersede all prior and contemporaneous agreements, understandings and
discussions, whether written or oral, relating to such subject matter in any way. 

 

		7.7	Governing Law; JURY TRIAL WAIVER; Jurisdiction and Venue. This
Agreement shall be governed by, and construed in accordance with, the laws of the State of New York. TO THE EXTENT NOT PROHIBITED BY APPLICABLE
LAW THAT CANNOT BE WAIVED, THE PURCHASER HEREBY WAIVES, AND COVENANTS THAT IT, HE OR SHE WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT
OR OTHERWISE), ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE, CLAIM, DEMAND, ACTION OR CAUSE OF ACTION ARISING IN WHOLE
OR IN PART UNDER, RELATED TO, BASED ON OR IN CONNECTION WITH THE NOTE(S) OR THE SUBJECT MATTER THEREOF, WHETHER NOW EXISTING OR HEREAFTER
ARISING AND WHETHER SOUNDING IN TORT OR CONTRACT OR OTHERWISE. Any issue, claim, demand, action or cause of action arising in whole or
in part under, related to, based on or in connection with this Agreement, the Note(s) or the subject matter thereof, whether now existing
or hereafter arising and whether sounding in tort or contract or otherwise shall be brought exclusively in the federal or state courts
in the Borough of Manhattan, New York, New York.

 

		7.8	No Third Party Beneficiary. This Agreement is for the sole benefit of the parties and their
permitted assigns and nothing herein expressed or implied shall give or be construed to give any person, other than the parties and such
permitted assigns, any legal or equitable rights hereunder.

 

		7.9	No Recourse Against Others. No director, officer, employee, manager,
member or equityholder (in its capacity as such) of the Company or any of its subsidiaries or affiliates shall have any liability for
the performance of any obligations of the Company under this Agreement or for any claim based on, in respect of, or by reason of such
obligations or their creation. The Purchaser, by executing this Agreement, waives and releases all such liability. The waiver and release
are part of the consideration for issuance of the Note(s) contemplated hereunder. 

 

    	 	11	 

     

    

 

 

		7.10	Further Assurances.
From time to time at the request of the Company and without any additional consideration, the Purchaser agrees to furnish to the Company
such further information or assurances, execute and deliver such additional documents, instruments, certificates and conveyances,
and take all such other actions and do such other things, as may be necessary or appropriate in the sole opinion the Company to carry
out the provisions of the Note(s) and this Agreement and to give effect to the transactions contemplated hereby and thereby.

 

[Signature Pages Follow]

 

    	 	12	 

     

    

 

IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the date first set forth above.

 

	 	BCP QUALTEK HOLDCO, LLC
	 	By: 	 
	 	 	Name:
	 	  	Title: 
	 	 	 
	 	ROTH CH ACQUISITION III CO.
	 	By:	 
	 	 	Name:
	 	 	Title:

 

	PURCHASER:	 
	 	 
	Name(s) of Purchaser:	 
	 	 
	Signature of Authorized Signatory of Purchaser:	 
	 	 
	Name of Authorized Signatory:	 
	 	 
	Title of Authorized Signatory:	 

 

	Address for Notice to Subscriber:	 
	 	Attention:	 
	 	Email:	 
	 	Telephone No.:	 

 

Note Amount: $

 

    	 

     

    

 

EXHIBIT A

 

	PURCHASER	NOTE AMOUNT
	 [l]	$[l]

 

    	 

     

    

 

EXHIBIT B

 

(attached)Exhibit 10.8

 

REGISTRATION RIGHTS AGREEMENT

 

This Registration Rights Agreement
(this “Agreement”) is made and entered into as of June 16, 2021 between Roth CH Acquisition III Co., a Delaware corporation
(the “Company”), and each of the several Purchasers signatory hereto (each such Purchaser, a “Purchaser”
and, collectively, the “Purchasers”).

 

This Agreement is made pursuant
to the Note Purchase Agreements between BCP QualTek HoldCo, LLC, the Company and each of the Purchasers signatory thereto (collectively,
the “NPAs”). To the extent the Company is the IPO Issuer (as defined in the NPAs) it has agreed to issue fully-paid
and non-assessable shares of Class A common stock upon contribution to its capital of the Notes by the Purchasers at a price of $8.00
per share (as adjusted, if applicable, pursuant to Section 3(a) of the Notes) in accordance with the terms of Section 3(a) of the respective
Notes (the “Shares”), and also hereby agrees the terms and conditions of this Agreement.

 

The Company and each Purchaser
hereby agrees as follows:

 

1.                 
Definitions.

 

Capitalized terms used
and not otherwise defined herein that are defined in the NPAs shall have the meanings given such terms in the NPAs. As used in this
Agreement, the following terms shall have the following meanings:

 

“Advice”
shall have the meaning set forth in Section 6(d).

 

“BCA”
means the Business Combination Agreement, dated as of June 16, 2021, by and among, the Company, (ii) Roth CH III Blocker Merger Sub, LLC,
a Delaware limited liability company and wholly-owned subsidiary of the Company (“Blocker
Merger Sub”), (iii) BCP QualTek Investors, LLC, a Delaware limited liability company, (iv) Roth CH III Merger Sub, LLC,
a Delaware limited liability company and wholly-owned subsidiary of the Company, (v) BCP QualTek HoldCo, LLC, a Delaware limited liability
company, and (vi) BCP QualTek, LLC, a Delaware limited liabity company, solely in its capacity as representative of the Blocker Owners
(as defined in the BCA) and the Company Unitholders (as defined in the BCA).

 

“Business
Day” means a day other than Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or
required by law to close.

 

“Closing
Date” means the date on which the transactions contemplated by the BCA have been consummated.

 

“Commission”
refers to the United States Securities and Exchange Commission.

 

    	 

     

    

 

“Effectiveness
Date” means, with respect to the Initial Registration Statement required to be filed hereunder, the 60th calendar
day following the Closing Date (or, in the event the Commission notifies the Company that it will “review” the Registration
Statement, the 90th calendar day following the date hereof) and with respect to any additional Registration Statements which
may be required pursuant to Section 2(c) or Section 3(c), the 60th calendar day following the date on which an additional Registration
Statement is required to be filed hereunder; provided, however, if such Effectiveness Date falls on a day that is not a
Business Day, then the Effectiveness Date shall be the next succeeding business day; provided, further, that if the Commission is closed
for operations due to a government shutdown, the Effectiveness Date shall be extended by the same amount of days that the Commission remains
closed for operations.

 

“Effectiveness
Period” shall have the meaning set forth in Section 2(a).

 

 

“Exchange
Act” means the Securities and Exchange Act of 1934, as amended.

 

“Filing
Date” means, with respect to the Initial Registration Statement required hereunder, the 10th Business Day following
the date on which the Company first files the Proxy Statement with the Commission and, with respect to any additional Registration Statements
which may be required pursuant to Section 2(c) or Section 3(c), the earliest practical date on which the Company is permitted by SEC Guidance
to file such additional Registration Statement related to the Registrable Securities.

 

“Holder”
or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities.

 

“Indemnified
Party” shall have the meaning set forth in Section 5(c).

 

“Indemnifying
Party” shall have the meaning set forth in Section 5(c).

 

“Initial
Registration Statement” means the initial Registration Statement filed pursuant to this Agreement.

 

“Losses”
shall have the meaning set forth in Section 5(a).

 

“Notes”
means the convertible notes issued pursuant to the NPAs.

 

“Person”
means any individual, corporation, partnership, joint venture, limited liability company, estate, trust, unincorporated association, any
federal, state, county or municipal government or any bureau, department or agency thereof and any fiduciary acting in such capacity on
behalf of any of the foregoing.

 

    	 	2	 

     

    

 

“Plan of
Distribution” shall have the meaning set forth in Section 2(a).

 

“Prospectus”
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information previously
omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430B promulgated by the Commission
pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus,
including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.

 

“Proxy
Statement” means the Proxy Statement to be filed in connection with the solicitation of proxies from holders of the Company
for the matters to be acted upon at the stockholder meeting approving the Transaction.

 

“Registrable
Securities” means, as of any date of determination, (a) all Shares and (b) any securities issued or then issuable upon any stock
split, dividend or other distribution, recapitalization or similar event with respect to the foregoing; provided, however, that
any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness
of any, or file another, Registration Statement hereunder with respect thereto) upon the earlier of such time as (i) they have been sold
under a Registration Statement required hereunder or pursuant to Rule 144 or (ii) it has been three years from the Closing Date.

 

“Registration
Statement” means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration
statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such
registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in any such registration statement.

 

“Rule 415”
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

 

“Rule 424”
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

 

    	 	3	 

     

    

 

“Selling
Stockholder Questionnaire” shall have the meaning set forth in Section 3(a).

 

“SEC Guidance”
means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission
staff and (ii) the Securities Act and the rules and regulations promulgated thereunder.

 

“Shares”
means, as defined in the Preamble, the Class A common stock of the Company issuable upon the automatic conversion of the Notes, pursuant
to their terms.

 

“Securities
Act” means the Securities Act of 1933, as amended.

 

“Subscription
Registrable Securities” means the securities subject to that that certain Registration Rights Agreement entered into by and
among the Company and the subscribers to those certain Subscription Agreements entered into concurrently herewith and subject to close
in connection with the Transaction.

 

“Transaction”
means the transactions described in the BCA, pursuant to which the Company will acquire BCP QualTek HoldCo, LLC on the terms and subject
to the conditions set forth therein.

 

2.                 
Shelf Registration.

 

(a)              
On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale
of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on
a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall contain (unless otherwise directed by at least
51% in interest of the Holders; provided, however, such direction shall be required by each Holder (aggregated with any
affiliated Holders) having an aggregate principal amount of Notes on the Closing Date of at least $10 million) substantially the “Plan
of Distribution” attached hereto as Annex A and substantially the “Selling Stockholder” section attached
hereto as Annex B; provided, however, that no Holder shall be required to be named as an “underwriter”
without such Holder’s express prior written consent. Subject to the terms of this Agreement, the Company shall use its commercially
reasonable efforts to cause a Registration Statement filed under this Agreement (including, without limitation, under Section 3(c)) to
be declared effective under the Securities Act as promptly as practicable after the filing thereof, but in any event no later than the
applicable Effectiveness Date, and shall use its commercially reasonable efforts to keep such Registration Statement continuously effective
under the Securities Act until the earliest of (i) the date that all Registrable Securities covered by such Registration Statement have
been sold thereunder or pursuant to Rule 144, (ii) the date that all Registrable Securities covered by such Registration Statement may
be sold pursuant to Rule 144 without volume
or manner-of-sale restrictions and without current public information (including pursuant to Rule 144(i)(2)), as reasonably determined
by the counsel to the Company, or (iii) the date that is three years from the Closing Date (the “Effectiveness
Period”). The Company shall request effectiveness of a Registration Statement as of 5:00 p.m. Eastern Time on a Business Day.
The Company shall promptly notify the Holders via facsimile or by e-mail of the effectiveness of a Registration Statement on the same
Business Day that the Company confirms effectiveness with the Commission, which shall be the date requested for effectiveness of such
Registration Statement. The Company shall, by 9:30 a.m. Eastern Time on the second Business Day after the effective date of such Registration
Statement, file a final Prospectus with the Commission as required by Rule 424. Nevertheless, the Company’s obligations to include
the Registrable Securities in a registration statement are contingent upon Holder furnishing in writing to the Company such other information
regarding Holder, the securities of the Company held by Holder and the intended method of disposition of the Registrable Securities as
shall be reasonably requested by the Company to effect the registration of the Registrable Securities, and Holder shall execute such documents
in connection with such registration as the Company may reasonably request that are customary of a selling stockholder in similar situations;
provided however, no Holder shall in connection with the foregoing be required to execute any lock-up or similar agreement or otherwise
be subject to any contractual restriction on the ability of such Holder to transfer the Shares.

    	 	4	 

     

    

 

(b)              
 Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that the resale
of all of the Registrable Securities as a secondary offering cannot, as a result of the application of Rule 415, be registered on a single
registration statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts
to file amendments to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities
permitted to be registered by the Commission.

 

(c)              
Notwithstanding any other provision of this Agreement, if the Commission or any SEC Guidance
sets forth a limitation on the number of securities permitted to be registered on a particular Registration
Statement, the number of securities to be registered on such Registration Statement will be
reduced as follows: 

 

First,
the Company shall reduce or eliminate any securities to be included other than Registrable Securities and the Subscription Registrable
Securities; and

 

Second,
the Company shall reduce the Registrable Securities pro rata among, collectively, the Registrable Securities
and Subscription Registrable Securities,

 

provided, however, that
the Company shall be obligated to use commercially reasonable efforts to advocate with the Commission for the registration of all of
the Registrable Securities in accordance with the SEC Guidance.

 

    	 	5	 

     

    

 

(d)              
In the event of a cutback hereunder, the Company shall give the Holder
at least five (5) Business Days prior written notice along with the calculations as to such Holder’s allotment. In the event the
Company amends the Initial Registration Statement in accordance with the foregoing, the Company will use its commercially reasonable efforts
to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company, one or more registration statements
to register the resale of those Registrable Securities that were not registered on the Initial Registration Statement, as amended.

 

(e)              
If Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register
the resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form
S-3 as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in
effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the
Commission.

 

(f)               
Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate
of a Holder as any Underwriter without the prior written consent of such Holder.

 

3.                 
Registration Procedures.

 

In connection with the Company’s
registration obligations hereunder, the Company shall:

 

(a)              
Subject to execution and delivery of the BCA, not less than three Business Days prior to the filing of each Registration Statement
and not less than one Business Day prior to the filing of any related Prospectus or any amendment or supplement thereto (including any
document that would be incorporated or deemed to be incorporated therein by reference), (i) furnish to each Holder copies of all such
documents proposed to be filed, which documents (other than those incorporated or deemed to be incorporated by reference) will be subject
to the review of such Holders, and (ii) cause its officers and directors, counsel and independent registered public accountants to respond
to such inquiries as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation
within the meaning of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments
or supplements thereto to which the Holders of a majority of the Registrable Securities shall reasonably object, provided that, the Company
is notified of such objection in writing
no later than two Business Days after the Holders have been so furnished copies of a Registration Statement or one (1) Business Day after
the Holders have been so furnished copies of any related Prospectus or amendments or supplements thereto. Each Holder agrees to furnish
to the Company a completed questionnaire in the form attached to this Agreement as Annex C (a “Selling Stockholder Questionnaire”)
on a date that is not less than ten Business Days prior to the Filing Date or by the end of the second (2nd) Business Day following the
date on which such Holder receives draft materials in accordance with this Section.

 

    	 	6	 

     

    

 

(b)              
(i) Use its commercially reasonable efforts to prepare and file with the Commission such amendments, including post-effective amendments,
to a Registration Statement and the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously
effective as to the applicable Registrable Securities for the Effectiveness Period and use its commercially reasonable efforts to prepare
and file with the Commission such additional Registration Statements in order to register the resale of all of the Registrable Securities
under the Securities Act, (ii) cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject
to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424, (iii) respond as promptly as reasonably
possible to any comments received from the Commission with respect to a Registration Statement or any amendment thereto and provide as
promptly as reasonably possible to the Holders true and complete copies of all correspondence from and to the Commission relating to a
Registration Statement (provided that, the Company shall excise any information contained therein which would constitute material non-public
information regarding the Company or any of its Subsidiaries), and (iv) comply in all material respects with the applicable provisions
of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a Registration Statement
during the applicable period in accordance (subject to the terms of this Agreement) with the intended methods of disposition by the Holders
thereof set forth in such Registration Statement as so amended or in such Prospectus as so supplemented.

 

(c)              
Unless otherwise provided in this Agreement, if during the Effectiveness Period the number of Registrable Securities at any time
exceeds 100% of the number of shares of Class A Common Stock then registered in a Registration Statement, use commercially reasonable
efforts to file, as soon as practicable, an additional Registration Statement covering the resale by the Holders of not less than the
number of such Registrable Securities.

 

    	 	7	 

     

    

 

(d)               Notify
the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) of this Section
3(d), be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as
promptly as reasonably possible (and, in the case of (i)(A) below, not less than one (1) Business Day prior to such filing) and (if
requested by any such Person) confirm such notice in writing within five (5) Business Days following the day a.(A) when a Prospectus
or any Prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed, (B) when the
Commission notifies the Company whether there will be a “review” of such Registration Statement and whenever the
Commission comments in writing on such Registration Statement, and (C) with respect to a Registration Statement or any
post-effective amendment, when the same has become effective, b. of any request by the Commission or any other federal or state
governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional information, c. of
the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness
of a Registration Statement covering any or all of the Registrable Securities or the initiation of any proceedings for that purpose,
d. of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from
qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any proceeding
for such purpose, e. of the occurrence of any event or passage of time that makes the financial statements included in a
Registration Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any
document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any
revisions to a Registration Statement, Prospectus or other documents so that, in the case of a Registration Statement or the
Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading, and f. of the occurrence or existence of any pending corporate development with respect to the Company that the
Company believes may be material and that, in the determination of the Company, makes it not in the best interest of the Company to
allow continued availability of a Registration Statement or Prospectus, provided, however, in no event shall any such
notice contain any information which would constitute material, non-public information regarding the Company or any of its
Subsidiaries.

 

(e)              
Use its commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping
or suspending the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification)
of any of the Registrable Securities for sale in any jurisdiction, at the earliest practicable moment.

 

(f)               
Furnish to such Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto,
including financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent
requested by such Holder, and all exhibits to the extent requested by such Holder (including those previously furnished or incorporated
by reference) promptly after the filing of such documents with the Commission; provided, that
any such item which is available on the EDGAR system (or successor thereto) need not be furnished in physical form.

    	 	8	 

     

    

 

(g)              
Subject to the terms of this Agreement, consent to the use of such Prospectus and each amendment or supplement thereto by each
of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment
or supplement thereto, except after the giving of any notice pursuant to Section 3(d).

 

(h)              
If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing
Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the
extent permitted by the NPAs, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered
in such names as any such Holder may request.

 

(i)                
Upon the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances
taking into account the Company’s good faith assessment of any adverse consequences to the Company and its stockholders of the premature
disclosure of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement
to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required
document so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of
the circumstances under which they were made, not misleading. If the Company
notifies the Holders in accordance with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the
requisite changes to such Prospectus have been made, then the Holders shall (x) suspend use of such Prospectus and immediately
discontinue offers and sales of the Registrable Securities under the Registration Statement until Holder receives copies of a supplemental
or amended prospectus that corrects the matters, misstatement(s) or omission(s) referred to above and receives notice that any post-effective
amendment has become effective or unless otherwise notified by the Company that it may resume such offers and sales and (y) maintain the
confidentiality of any information included in such written notice delivered by the Company unless otherwise required by law or subpoena.
If so directed by the Company, Holder will destroy all copies of the prospectus covering the Registrable Securities in Holder’s
possession; provided, however, that this obligation to destroy all copies of the prospectus covering the Registrable Securities shall
not apply (i) to the extent Holder is required to retain a copy of such prospectus (a) in order to comply with applicable legal, regulatory,
self-regulatory or professional requirements or (b) in accordance with a bona fide pre-existing document retention policy or (ii) to copies
stored electronically on archival servers as a result of automatic data back-up.
The Company will use its commercially reasonable efforts to ensure that the use of the Prospectus may be resumed as promptly
as is practicable. The Company shall be entitled to exercise its right under this Section 3(i) to suspend the availability of a Registration
Statement and Prospectus no more than three (3) times or for more than 60 total calendar days (which need not be consecutive days) in
any 12-month period. Holder may deliver written notice (an “Opt-Out
Notice”) to the Company requesting that Holder not receive notices from the Company regarding the suspension of the Registration
Statement; provided, however, that Holder may later revoke any such Opt-Out Notice in writing. Following receipt of an Opt-Out Notice
from Holder (unless subsequently revoked), (i) the Company shall not deliver any such notices to Holder and Holder shall no longer be
entitled to the rights associated with any such notice and (ii) each time prior to Holder’s intended use of an effective Registration
Statement, Holder will notify the Company in writing at least two (2) business days in advance of such intended use, and if a notice of
a suspension was previously delivered (or would have been delivered but for the provisions of this Section) and the related suspension
period remains in effect, the Company will so notify the Holder, within one (1) business day after Holder’s notification to the
Company, by delivering to Holder a copy of such previous notice of suspension, and thereafter will provide Holder with the related notice
of the conclusion of such suspension promptly following its availability.

 

    	 	9	 

     

    

 

(j)                
Otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities
Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement
or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at
any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.

 

(k)              
The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Class
A Common Stock beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and
dispositive control over the shares.

 

4.                 
Registration Expenses. All fees and expenses incident to the performance of, or compliance with, this Agreement by the Company
shall be borne by the Company. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all
registration and filing fees (including, without limitation, fees and expenses of the Company’s counsel and independent registered
public accountants) (A) with respect to filings made with the Commission, (B) with respect to filings required to be made with any trading
market on which the Class A Common Stock is then listed for trading, and (C) in compliance with applicable state securities or “blue
sky” laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements of counsel for the
Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities), (ii)
printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities), (iii) messenger, telephone
and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company
so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation
of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred
in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and
expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses
incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall
the Company be responsible for any broker or similar commissions of any Holder.

 

    	 	10	 

     

    

 

5.                 
Indemnification.

 

(a)               Indemnification
by the Company. The Company shall, notwithstanding any termination of this Agreement, to the extent permitted by law, indemnify
and hold harmless each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell
Registrable Securities as principal as a result of a pledge or any failure to perform under a margin call of Class A common stock of
the Company), investment advisors and employees (and any other Persons with a functionally equivalent role of a Person holding such
titles, notwithstanding a lack of such title or any other title) of each of them, each Person who controls any such Holder (within
the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, members,
stockholders, partners, agents and employees (and any other Persons with a functionally equivalent role of a Person holding such
titles, notwithstanding a lack of such title or any other title) of each such controlling Person, to the fullest extent permitted by
applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable
attorneys’ fees) and expenses (collectively, “Losses”), as incurred, arising out of or relating to (1) any
untrue or alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus or any form of
prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission
or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any
Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (2) any violation or
alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation
thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the
extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to
the Company by such Holder expressly for use therein or (ii) in the case of an occurrence of an event of the type specified in
Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company has notified
such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt
by such Holder of the Advice contemplated in Section 6(d). The Company shall notify the Holders promptly of the institution, threat or
assertion of any proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is
aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person
and shall survive the transfer of any Registrable Securities by any of the Holders in accordance with Section 6(h).

 

    	 	11	 

     

    

 

(b)              
Indemnification by Holders. Each Holder shall, to the extent permitted by law, severally and not jointly, indemnify and
hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning of
Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such controlling
Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, to the extent arising out of or
based solely upon: any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus,
or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission
of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement
thereto, in light of the circumstances under which they were made) not misleading to the extent, but only to the extent, that such untrue
statement or omission is contained in any information so furnished in writing by such Holder to the Company expressly for inclusion in
such Registration Statement or such Prospectus, such Prospectus or in any amendment or supplement thereto. In no event shall the liability
of a selling Holder be greater in amount than the dollar amount of the net proceeds received by such Holder upon the sale of the Registrable
Securities included in the Registration Statement giving rise to such indemnification obligation.

 

(c)              
Conduct of Indemnification Proceedings. If any proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity is
sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve
the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be
finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure
shall have materially adversely prejudiced the Indemnifying Party.

 

    	 	12	 

     

    

 

An Indemnified
Party shall have the right to employ separate counsel in any such proceeding and to participate in the defense thereof, but the fees and
expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in
writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such proceeding
and to employ counsel reasonably satisfactory to such Indemnified Party in any such proceeding, or (3) the named parties to any such proceeding
(including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified Party
shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified
Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to
employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense
thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party).
The Indemnifying Party shall not be liable for any settlement of any such proceeding effected without its written consent, which consent
shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party,
effect any settlement of any pending proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such proceeding.

 

Subject to the
terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent
incurred in connection with investigating or preparing to defend such proceeding in a manner not inconsistent with this Section) shall
be paid to the Indemnified Party, as incurred, within twenty (20) Business Days of written notice thereof to the Indemnifying Party, provided
that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such
actions for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject
to appeal or further review) not to be entitled to indemnification hereunder.

 

(d)              
Contribution. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to
hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such
Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party
in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations.
The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any
action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material
fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party,
and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement
or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set
forth in this Agreement, any reasonable attorneys’ or other fees or expenses incurred by such party in connection with any proceeding
to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was
available to such party in accordance with its terms.

 

    	 	13	 

     

    

 

The parties hereto
agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or
by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding
paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount
of the proceeds received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.

 

The indemnity and
contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified
Parties.

 

6.                 
Miscellaneous.

 

(a)              
Remedies. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement,
each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement,
including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each
Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any
of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of
such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.

 

(b)              
No Piggyback on Registrations; Prohibition on Filing Other Registration Statements. The Company shall not file any other
registration statements until the earlier of (i) the date that all Registrable Securities are registered pursuant to a Registration Statement
that is declared effective by the Commission and (ii) the expiration of the Effectivness Period, provided that this Section 6(b) shall
not prohibit the Company (i) from filing amendments to registration statements filed prior to the date of this Agreement; (ii) from filing
a registration statement pursuant to previously existing contractual obligations to include securities issued or to be issued prior to
the date of this Agreement, as well as the Subscription Registrable Securities, (iii) from filing a registration statement on Form S-4
(as promulgated under the Securities Act) relating to equity securities to be issued solely in connection with any acquisition of any
entity or business or their then equivalents, (iv) from filing
a registration statement on Form S-8 (as promulgated under the Securities Act) relating to equity securities issuable in connection with
the Company’s stock option or other employee benefit plans and (v) from filing a registration statement for securities issued in
accordance with, and pursuant to, the terms of the BCA (including shares of Class A Common Stock issuable in connection with the Transactions).

 

    	 	14	 

     

    

 

(c)              
Compliance. Subject to Section 3(j), each Holder covenants and agrees that it will comply with the prospectus delivery requirements
of the Securities Act as applicable to it (unless an exemption therefrom is available) in connection with sales of Registrable Securities
pursuant to a Registration Statement.

 

(d)              
Discontinued Disposition. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice
from the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue
disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the “Advice”)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed (excluding, for
the avoidance of doubt, dispositions conducted pursuant to Rule 144). The Company will use its commercially reasonable efforts to ensure
that the use of the Prospectus may be resumed as promptly as is practicable.

 

(e)              
Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended,
modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be
in writing and signed by the Company and the Holders of 51% or more of the then outstanding Registrable Securities; provided, however,
any material modification, waiver or termination to the obligations of the Company or Holder hereunder shall require the prior written
consent of each Holder (aggregated with any affiliated Holders) having an aggregate principal amount of Notes at the Closing of at least
$10 million. If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or amendment done in
compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall be reduced pro
rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities shall be omitted from such
Registration Statement.

 

(f)               
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be delivered as set forth in the NPAs.

 

(g)              
Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations
hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign
their respective rights hereunder in the manner and to the Persons as permitted under the NPAs.

 

    	 	15	 

     

    

 

(h)              
No Inconsistent Agreements. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall
the Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities,
that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions
hereof.

 

(i)                
Execution and Counterparts. This Agreement may be executed in two or more counterparts, all of which when taken together
shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered
by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile
or “.pdf” signature page were an original thereof.

 

(j)                
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall
be determined in accordance with the laws of the State of Delaware, without giving effect to the principles of conflicts of law thereof.

 

(k)              
Cumulative Remedies. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.

 

(l)                
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by
such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.

 

(m)            
Headings. The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not
be deemed to limit or affect any of the provisions hereof.

 

    	 	16	 

     

    

 

(n)               Independent
Nature of Holders’ Obligations and Rights. The obligations of each Holder hereunder are several and not joint with the
obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of
any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action
taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint
venture or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a
group or entity with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the
Company acknowledges that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with
respect to such obligations or transactions. Each Holder shall be entitled to protect and enforce its rights, including without
limitation the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as an
additional party in any proceeding for such purpose. The use of a single agreement with respect to the obligations of the Company
was solely in the control of the Company, not the action or decision of any Holder, and was done solely for the convenience of the
Company and not because it was required or requested to do so by any Holder. It is expressly understood and agreed that each
provision contained in this Agreement is between the Company and a Holder, solely, and not between the Company and the Holders
collectively and not between and among Holders.

 

(Signature
Pages Follow)

 

    	 	17	 

     

    

 

IN WITNESS WHEREOF, the parties
have executed this Registration Rights Agreement as of the date first written above.

 

	 	ROTH CH ACQUISITION III CO.
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

[SIGNATURE PAGE OF HOLDERS FOLLOWS]

 

    	 

     

    

 

[SIGNATURE
PAGE OF HOLDERS TO ROCC RRA]

 

	Name of Holder:	 
	 	 
	Signature of Authorized Signatory of Holder:	 
	 	 
	Name of Authorized Signatory:	 
	 	 
	Title of Authorized Signatory:	 

 

[SIGNATURE PAGES CONTINUE]

 

    	 

     

    

Annex A

 

Plan of Distribution

 

Each Selling Stockholder (the
 “Selling Stockholders”) of the securities and any of their pledgees, assignees and successors-in-interest may, from
time to time, sell any or all of their securities covered hereby on the principal trading market for such securities or any other stock
exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated
prices. A Selling Stockholder may use any one or more of the following methods when selling securities:

 

		·	ordinary brokerage transactions and transactions in which the
broker-dealer solicits Holders;

 

		·	block trades in which the broker-dealer will attempt to
sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;

 

		·	purchases by a broker-dealer as principal and resale by
the broker-dealer for its account;

 

		·	an exchange distribution in accordance with the rules of the
applicable exchange;

 

		·	privately negotiated transactions;

 

		·	settlement of short sales;

 

		·	in transactions through broker-dealers that agree with the
Selling Stockholders to sell a specified number of such securities at a stipulated price per security;

 

		·	through the writing or settlement of options or other hedging
transactions, whether through an options exchange or otherwise;

 

		·	a combination of any such methods of sale; or

 

		·	any other method permitted pursuant to applicable law.

 

The Selling Stockholders may
also sell securities under Rule 144 or any other exemption from registration under the Securities Act, if available, rather than under
this prospectus.

 

Broker-dealers engaged
by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the Holder of securities, from the Holder)
in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case
of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal
transaction a markup or markdown in compliance with FINRA IM-2440.

 

    	 

     

    

 

In connection with the sale
of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling
Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities
to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).

 

The Selling Stockholders and
any broker-dealers or agents that are involved in selling the securities may be deemed to be “underwriters” within the meaning
of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly
or indirectly, with any person to distribute the securities.

 

The Company is required to
pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify
the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.

 

We agreed to keep this prospectus
effective until the earlier of (i) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act
or any other rule of similar effect, (ii) they may be sold pursuant to Rule 144 without volume or manner-of-sale restrictions, as determined
by the Company; or (iii) it has been three years from the Closing Date. The resale securities will be sold only through registered or
licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities
covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the
registration or qualification requirement is available and is complied with.

 

Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market
making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement
of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules
and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common stock by the Selling
Stockholders or any other person.

 

    	 	A-1	 

     

    

 

We will make copies of this prospectus available
to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each Holder at or prior to the
time of the sale (including by compliance with Rule 172 under the Securities Act).

 

    	 	A-2	 

     

    

 

Annex B

 

SELLING STOCKHOLDER

 

The common stock being offered
by the Selling Stockholders are those previously issued to the Selling Stockholders in connection with the Transaction. For additional
information regarding the issuances of those shares of common stock, see “Private Placement of Common Shares” above. We are
registering the shares of common stock in order to permit the Selling Stockholders to offer the shares for resale from time to time. Except
for the ownership of the shares of common stock, the Selling Stockholders have not had any material relationship with us within the past
three years.

 

The table below lists the
Selling Stockholders and other information regarding the beneficial ownership of the shares of common stock by each of the Selling Stockholders.
The second column lists the number of shares of common stock beneficially owned by each Selling Stockholder, based on its ownership of
the shares of common stock, as of ________.

 

The third column lists the
shares of common stock being offered by this prospectus by the Selling Stockholders.

 

In accordance with the terms
of a registration rights agreement with the Selling Stockholders, this prospectus generally covers the resale of the sum of (i) the number
of shares of common stock issued to the Selling Stockholders in the __________________. The fourth column assumes the sale of all of the
shares offered by the Selling Stockholders pursuant to this prospectus.

 

The Selling Stockholders may
sell all, some or none of their shares in this offering. See “Plan of Distribution.”

 

    	 

     

    

 

	

Name of Selling Stockholder	Number of shares of Common Stock Owned Prior to Offering	Maximum Number of shares of Common Stock to be Sold Pursuant to this Prospectus	Number of shares of Common Stock Owned After Offering

 

    	 	B-2	 

     

    

 

Annex C

 

Selling Stockholder Notice and Questionnaire

 

The undersigned beneficial
owner of common stock (the “Registrable Securities”) of Roth CH Acquisition III Co., a Delaware corporation (the “Company”),
understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”)
a registration statement (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities
Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with the terms of the
Registration Rights Agreement (the “Registration Rights Agreement”) to which this document is annexed. A copy of the
Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise
defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.

 

Certain legal consequences
arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or
not being named as a selling stockholder in the Registration Statement and the related prospectus.

 

NOTICE

 

The undersigned beneficial
owner (the “Selling Stockholder”) of Registrable Securities hereby elects to include the Registrable Securities owned
by it in the Registration Statement.

 

    	 

     

    

 

The undersigned hereby provides the following
information to the Company and represents and warrants that such information is accurate:

 

QUESTIONNAIRE

 

		1.	Name.

 

		(a)	Full Legal Name of Selling Stockholder

 

	 
	 

		(b)	Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities
are held:

	 
	 

		(c)	Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone
or with others has power to vote or dispose of the securities covered by this Questionnaire):

 

	 
	 

 

		2.	Address for Notices to Selling Stockholder:

 

	 
	 
	 
	Telephone:

 

Fax:

	 
	 

 

Contact Person:

	 
	 

 

3. Broker-Dealer Status:

 

		(a)	Are you a broker-dealer?

 

		Yes  ̈	No  ̈	

 

    	 

     

    

 

		(b)	If “yes” to Section 3(a), did you receive your Registrable Securities as compensation for
investment banking services to the Company?

 

		Yes  ̈	No  ̈	

 

		Note:	If “no” to Section 3(b), the Commission’s
staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

		(c)	Are you an affiliate of a broker-dealer?

 

		Yes  ̈	No  ̈	

 

		(d)	If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities
in the ordinary course of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements
or understandings, directly or indirectly, with any person to distribute the Registrable Securities?

 

		Yes  ̈	No  ̈	

 

		Note:	If “no” to Section 3(d), the Commission’s
staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

4. Beneficial Ownership of Securities
of the Company Owned by the Selling Stockholder.

 

Except as set forth below in this
Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable
pursuant to the NPAs.

 

		(a)	Type and Amount of other securities beneficially owned by the Selling Stockholder:

 

	 	 
	 	 
	 	 

 

5. Relationships with the Company:

 

Except as set forth below, neither
the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities
of the undersigned) has held any position or office or has had any other material relationship with the Company (or its
predecessors or affiliates) during the past three years.

 

    	 

     

    

 

State any exceptions here:

 

	 	 
	 	 
	 	 

 

The undersigned agrees to
promptly notify the Company of any material inaccuracies or changes in the information provided herein that may occur subsequent to the
date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify
the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.

 

By signing below, the undersigned
consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion of such information
in the Registration Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands that such
information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related
prospectus and any amendments or supplements thereto.

 

IN WITNESS WHEREOF the undersigned,
by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized
agent.

 

	Date:		 	Beneficial Owner:	 
	 	 	 	 	 
	 	 	 	By:	 
	 	 	 	 	Name:
	 	 	 	 	Title:

 

PLEASE EMAIL A .PDF COPY OF THE COMPLETED AND
EXECUTED NOTICE AND QUESTIONNAIRE TO:

 

Janeane Ferrari at Loeb & Loeb LLP, email:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]